EFFICACY OF ABATACEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS REFRACTORY TO TNF-α
https://doi.org/10.15690/vsp.v14i2.1304
Abstract
The article describes the experience of the application of genetically engineered biological drug and an inhibitor of T lymphocyte costimulation – abatacept – at a standard dose in a child with polyarticular juvenile idiopathic arthritis. The disease was characterized by the development of uveitis, as well as the ineffectiveness of two inhibitors of tumour necrosis factor α treatment. Successful relief of acute inflammatory reaction of the joints on the background of the normalization of laboratory indicators of disease severity in the application of abatacept in combination with methotrexate was detected. The study gave the characteristics of the dynamics of clinical recovery of the patient and described the dynamic changes of clinical and laboratory symptoms. A steady improvement of the child under nine-month follow-up on the background of the selected scheme basic anti-inflammatory therapy should be noted.
About the Authors
Yu. M. Spivakovskii
V.I. Razumovskii Saratov State Medical University, Saratov, Russian Federation
Russian Federation
Russian Federation
Yu. V. Chernenkov
V.I. Razumovskii Saratov State Medical University, Saratov, Russian Federation
Russian Federation
Russian Federation
A. Yu. Spivakovskaya
V.I. Razumovskii Saratov State Medical University, Saratov, Russian Federation
Russian Federation
Russian Federation
O. V. Skupova
V.I. Razumovskii Saratov State Medical University, Saratov, Russian Federation
Russian Federation
Russian Federation
E. N. Shul'gina
V.I. Razumovskii Saratov State Medical University, Saratov, Russian Federation
Russian Federation
Russian Federation
References
1. Textbook of Pediatric Rheumatology. 6th edn. J. Cassidy, R. Petty, R. Laxer, C. Lindsley (eds.). Philadelphia, Saunders Elsevier, 2011.
2. Alekseeva E. I., Baranov A. A., Bzarova T. M., Valieva S. I., Denisova R. V., Isaeva K. B., Karagulyan N. A., Litvitskii P. F., Mitenko E. V., Sleptsova T. V. Fetisova A. N., Chistyakova E. G. Yuvenil'nyi artrit: klinicheskie rekomendatsii dlya pediatrov. Detskaya revmatologiya. Pod red. A. A. Baranova, E. I. Alekseevoi [Juvenile Arthritis: Clinical Guidelines for Pediatricians. Pediatric Rheumatology. Edited by A.A. Baranov, E.I. Alexeeva]. Moscow, Pediatr"", 2013. 120 p.
3. Revmatologiya: Klinicheskie rekomendatsii. Izd. 2-e, ispr. i dop. Pod red. E. L. Nasonova [Rheumatology: Clinical Guidelines. 2nd edition, revised and enlarged. Edited by E.L. Nasonov]. Moscow, GEOTAR-Media, 2011. 752 p.
4. Alekseeva E. I., Litvitskii P. F., Skudarnov E. V., Shakhbazyan I. V. Yuvenil'nyi revmatoidnyi artrit. V kn.: «Prakticheskoe rukovodstvo po detskim boleznyam». Pod obshch. red. V. F. Kokolinoi, A. G. Rumyantseva [Juvenile Rheumatoid Arthritis. In book: "Practical Guide to Childhood Diseases". Edited by V.F. Kokolinaya, A.G. Rumyantsev]. Moscow, Medpraktika-M, 2009. 580–681 p.
5. Alekseeva E. I., Litvitskii P. F. Yuvenil'nyi revmatoidnyi artrit: etiologiya, patogenez, klinika. Algoritmy diagnostiki i lecheniya [Juvenile Rheumatoid Arthritis: Etiology, Pathogenesis, Clinical Features. Algorithms of Diagnosis and Treatment]. Moscow, Vedi, 2007. 368 p.
6. Malievskii V. A. Yuvenil'nye artrity: epidemiologiya, mediko-sotsial'nye i ekonomicheskie posledstviya, kachestvo zhizni. Avtoref. dis. … dokt. med. nauk [Juvenile Arthritis: Epidemiology; Medical, Social and Economic Impact, Quality of Life. Author’s abstract]. Moscow, 2006. 38 p.
7. Ruperto N., Murray K.J., Gerloni V., Wulffraat N., de Oliveira S.K.F., Falcini F., Dolezalova P., Alessio M., Burgos-Vargas R., Corona F., Vesley R., Foster H., Davidson J., Zulian F., Asplin L., Baildam E., Con suegra J. G., Ozdogan H., Saurenmann R., Joos R., Pistorio A., Woo P., Martini A. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 2004; 50: 2191–2201.
8. Baranov A.A., Alekseeva E.I., Bzarova T.M., Valieva S.I., Denisova R.V., Isaeva K.B., Karagulyan N.A., Litvitskii P.F., Mitenko E.V., Sleptsova T.V., Fetisova A.N., Chistyakova E.G., Taibulatov N.I., Morev S.Yu. Minutes of the management of patients with juvenile arthritis. Voprosy sovremennoi pediatrii = Current pediatrics. 2013; 12 (1): 37–56.
9. Beukelman T., Patkar N., Saag K.G., Tolleson-Rinehart S., Cron R.Q., DeWitt E.M., Ilovite N.T., Kimura Y., Laxer R.M., Lovell D.G., Martini A., Rabinovich C.E., Ruperto N. American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features. Arthritis Care & Res. 2011; 63 (4): 465–482.
10. Ravelli A., Martini A. Juvenile idiopathic arthritis. Lancet. 2007; 369: 767–778.
11. Baranov A. A., Alekseeva E. I., Valieva S. I., Bzarova T. M., Denisova R. V., Chistyakova E. G., Sleptsova T. V., Mitenko E. V. Biological therapy in pediatric rheumatology. Voprosy sovremennoi pediatrii = Current pediatrics. 2011; 10 (1): 5–16.
12. Salugina S.O., Fedorov E.S. Modern approaches to the treatment of juvenile arthritis. Farmateka = Pharmateca. 2013; 20 (273): 42–48.
13. Loskutova O.Yu. Effektivnost' i bezopasnost' genno-inzhenernykh biologicheskikh preparatov (infliksimab, etanertsept, abatatsept) u detei s razlichnymi variantami yuvenil'nogo idiopaticheskogo artrita. Avtoref. dis. … kand. med. nauk [Efficacy and Safety of Genetically Engineered Biological Agents (Infliximab, Etanercept, Abatacept) in Children with Various Forms of Juvenile Idiopathic Arthritis. Author’s abstract]. Moscow, 2015. 24 p.
14. Lovell D. J., Giannini E. H., Reiff A., Cawkwell G. D., Silver man E. D., Nocton J. J., Stein L. D., Gedalia A., Ilowite N. T., Wal lace C. A., Whitmore J., Finck B. K. For the Pediatric Rheumatology Collaborative Study Group: Etanercept in children with polyarticular juvenile rheumatoid arthritis. N. Engl. J. Med. 2000; 342: 763–769.
15. Lovell D. J., Ruperto N., Goodman S., Reiff A., Jung L., Jarosova K., Nemcova D., Mouy R., Sandborg C., Bohnsack J., Elewaut D., Foeldvari I., Gerloni V., Rovensky J., Minden K., Vehe R. K., Weiner L. W., Horneff G., Huppertz H. I., Olson N. Y., Medich J. R., Carereri-De-Prati R., McIlraith M. J., Giannini E. H., Martini A. Pediatric Rheumatology Collaborative Study Group, Peadiatric Rheumatology International Trials Organisation: Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N. Engl. J. Med. 2008; 359: 810–820.
16. Ruperto N., Lovell D. J., Cuttica R., Wilkinson N., Woo P., Espada G., Wouters C., Silverman E. D., Balough Z., Henrickson M., Apaz M. T., Baildam E., Fasth A., Gerloni V., Lahdenne P., Prieur A. M., Ravelli A., Saurenmann R. K., Gamir M. L., Wulffraat N., Marodi L., Petty R. E., Joos R., Zulian F., McCurdy D., Myones B. L., Nagy K., Reuman P., Szaer I., Beutler A., Keenan G., Clark J., Visvanathan S., Fasanmade A., Raychavdhuri A., Mendelsohn A., Martini A., Giannini E. H. Тhe Paediatric Rheumatology International Trials Organisation, the Pediatric Rheumatology Collaborative Study Group: A randomized, placebocontrolled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2007; 56: 3096–3106.
17. Kel'tsev V. A. Klinicheskaya artrologiya (rukovodstvo dlya vrachei) [Clinical Arthrology (Manual for Physicians)]. Samara, Sodruzhestvo, 2010, 616 p.
18. Nasonov E. L. New aspects of pharmacotherapy of rheumatoid arthritis - blockade of co-stimulation of T-lymphocytes. Russkii meditsinskii zhurnal = Russian medical journal. 2009; 17 (3): 2–7.
19. Hashkes P. J., Laxer R. M. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005; 294: 1671–1684.
20. Schett G. Review: Immune cells and mediators of inflammatory arthritis. Autoimmunity. 2008; 41: 224–229.
21. Ruperto N. Abbatatsept: new possibilities in the treatment of children with polyarticular juvenile idiopathic arthritis. Voprosy sovremennoi pediatrii = Current pediatrics. 2010; 9 (2): 32–39.
22. Nasonov E.L., Karateev D.E. Application of costimulation blocker abatacept T lymphocytes in rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya = Science-practical rheumatology. 2010; 4 (2): 9–27.
23. Nikishina I.P. Application of abatacept in treatment of juvenile arthritis. Nauchno-prakticheskaya revmatologiya = Science-practical rheumatology. 2010; 4 (2): 42–45.
24. Bzarova T.M., Alekseeva E.I., Valieva S.I., Chomakhidze A.M., Isaeva K.B., Lisitsyn A.O., Denisova R.V. Application experience of T lymphocyte costimulation inhibitor abatacept patient polyarticular variant of juvenile rheumatoid arthritis. Voprosy sovremennoi pediatrii = Current pediatrics. 2010; 9 (4): 147–154.
25. Kel'tsev V.A., Grebenkina L.I., Pryanichnikova N.S., Goryunov S.A., Lagoda N.V. Efficacy and safety of abatacept in combination with methotrexate and methotrexate monotherapy in patients with polyarticular juvenile idiopathic arthritis option. Voprosy sovremennoi pediatrii = Current pediatrics. 2012; 11 (6): 103–109.
26. Alexeeva E.I., Valieva S.I., Bzarova T.M., Denisova R.V., Isaeva K.B., Sleptsova T.V., Mitenko E.V., Taibulatov N.I. Results of an open clinical trial phase IV study of the efficacy and safety of abatacept in children and adolescents with polyarticular juvenile idiopathic arthritis without systemic manifestations in Russia. Voprosy sovremennoi pediatrii = Current pediatrics. 2013; 12 (4): 62–72.
27. Maneiro R.J., Salgado E., Carmona L., Gomez-Reino J. J. Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and metaanalysis. Semin. Arthritis Rheum. 2013; 43 (1): 9–17.
28. Lopez-Olivo M.A., Tayar J.H., Martinez-Lopez J.A., Pollono E.N., Cueto J.P., Gonzales-Crespo M.R., Fulton S., Suarez-Almazor M.E. Malignancies in patients with rheumatoid arthritis treated with biologic therapy. A Meta-analysis. JAMA. 2012; 308 (9): 898–908.
29. Weinblatt M.E., Schiff M., Valente R., van der Heijde D., Citera G., Zhao C., Maldonado M., Fleishmann R. Head-to-Head comparison of Subcutaneous Abatacept Versus Adalimumab For Rheumatoid Arthritis. Arthritis Rheum. 2013; 65 (1): 28–38.
30. Balykova L.A., Ivyanskaya N.V., Krasnopol'skaya A.V., Trupanova P.A. Abatacept in the treatment of juvenile idiopathic arthritis: data from international studies and experience in the use of the Republic of Mordovia. Voprosy sovremennoi pediatrii = Current pediatrics. 2014; 13 (2): 28–36.
Review
For citations:
Spivakovskii Yu.M., Chernenkov Yu.V., Spivakovskaya A.Yu., Skupova O.V., Shul'gina E.N. EFFICACY OF ABATACEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS REFRACTORY TO TNF-α. Current Pediatrics. 2015;14(2):305-308. (In Russ.) https://doi.org/10.15690/vsp.v14i2.1304
Views:
1009
Email this article 
